Top compounds associated with response to TAS2R5


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.03
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.072 0.03
mRNA R428 CTRPv2 pan-cancer AAC 0.095 0.03
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.03
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.079 0.03
mRNA azacitidine CTRPv2 pan-cancer AAC 0.081 0.03
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.086 0.03
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.073 0.03
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.073 0.03
Download CSV